Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy.

van Leth F, Wit FW, Reiss P, Schattenkerk JK, van der Ende ME, Schneider MM, Mulder JW, Frissen PH, de Wolf F, Lange JM.

HIV Med. 2004 Mar;5(2):74-81.

2.

Detection of Legionella pneumophila serogroup 1 antigen in bronchoalveolar lavage fluid by an immunochromatographic assay.

Wever PC, Notermans DW, Tulevski II, Schattenkerk JK, de Jong MD.

J Clin Microbiol. 2003 May;41(5):2265. No abstract available.

3.

Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia.

Benfield TL, Schattenkerk JK, Hofmann B, Jensen BN, Nielsen TL, Lundgren JD.

J Infect Dis. 1994 May;169(5):1170-3.

PMID:
8169417
4.

Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.

Godfried MH, van der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, van Deventer SJ, Sauerwein HP.

AIDS. 1993 Jan;7(1):33-6.

PMID:
8382926
5.

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M.

J Virol. 1992 Mar;66(3):1354-60.

6.

Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers.

Teeuwsen VJ, Lange JM, Keet R, Schattenkerk JK, Debouck C, van den Akker R, Goudsmit J, Osterhaus AD.

AIDS. 1991 Aug;5(8):971-9.

PMID:
1723280
7.

Multiple primary malignant melanomas in an HIV-positive man.

van Ginkel CJ, Sang RT, Blaauwgeers JL, Schattenkerk JK, Mooi WJ, Hulsebosch HJ.

J Am Acad Dermatol. 1991 Feb;24(2 Pt 1):284-5. No abstract available.

PMID:
2007677
8.

Increased resting energy expenditure in human immunodeficiency virus-infected men.

Hommes MJ, Romijn JA, Godfried MH, Schattenkerk JK, Buurman WA, Endert E, Sauerwein HP.

Metabolism. 1990 Nov;39(11):1186-90.

PMID:
2233280
9.

HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.

Mulder JW, Krijnen P, Goudsmit J, Schattenkerk JK, Reiss P, Lange JM.

Genitourin Med. 1990 Jun;66(3):138-41.

10.

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J, et al.

J Clin Invest. 1988 Dec;82(6):1908-14.

11.

Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.

de Wit R, Schattenkerk JK, Boucher CA, Bakker PJ, Veenhof KH, Danner SA.

Lancet. 1988 Nov 26;2(8622):1214-7.

PMID:
2903953
12.

Splenectomy in kala-azar.

Rees PH, Kager PA, Kyambi JM, Ayim EN, Bhatt KM, Schattenkerk JK.

Trop Geogr Med. 1984 Sep;36(3):285-92.

PMID:
6506208
13.

Retinal hemorrhages in kala-azar.

De Cock KM, Rees PH, Klauss V, Kasili EG, Kager PA, Schattenkerk JK.

Am J Trop Med Hyg. 1982 Sep;31(5):927-30. No abstract available.

PMID:
7125060

Supplemental Content

Loading ...
Support Center